Does IXAZOMIB Cause Myelosuppression? 121 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 121 reports of Myelosuppression have been filed in association with IXAZOMIB (NINLARO). This represents 0.5% of all adverse event reports for IXAZOMIB.
121
Reports of Myelosuppression with IXAZOMIB
0.5%
of all IXAZOMIB reports
11
Deaths
35
Hospitalizations
How Dangerous Is Myelosuppression From IXAZOMIB?
Of the 121 reports, 11 (9.1%) resulted in death, 35 (28.9%) required hospitalization, and 4 (3.3%) were considered life-threatening.
Is Myelosuppression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IXAZOMIB. However, 121 reports have been filed with the FAERS database.
What Other Side Effects Does IXAZOMIB Cause?
Plasma cell myeloma (3,249)
Death (2,845)
Off label use (2,841)
Diarrhoea (2,560)
Pneumonia (1,583)
Nausea (1,568)
Fatigue (1,456)
Neuropathy peripheral (1,162)
Vomiting (977)
Thrombocytopenia (964)
What Other Drugs Cause Myelosuppression?
CYCLOPHOSPHAMIDE (3,603)
CARBOPLATIN (2,624)
TRASTUZUMAB (2,552)
PACLITAXEL (2,522)
TISLELIZUMAB (2,142)
CYTARABINE (1,869)
VENETOCLAX (1,864)
CISPLATIN (1,849)
BEVACIZUMAB (1,744)
SODIUM (1,696)
Which IXAZOMIB Alternatives Have Lower Myelosuppression Risk?
IXAZOMIB vs IXEKIZUMAB
IXAZOMIB vs JAKAFI
IXAZOMIB vs JAKAVI
IXAZOMIB vs JANUMET
IXAZOMIB vs JANUVIA